Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 71
Filter
1.
Life Sci ; 309: 121014, 2022 Nov 15.
Article in English | MEDLINE | ID: mdl-36179814

ABSTRACT

Positive allosteric modulators (PAMs) of metabotropic glutamate receptor type 5 (mGluR5) potentiate positive receptor response and may be effective for the treatment of schizophrenia and cognitive disorders. Although crystal structures of mGluR5 complexed with the negative allosteric modulators (NAMs) are available, no crystal structure of mGluR5 complexed with PAM has been reported to date. Thus, conformational changes associated with the binding of PAMs to mGluR5 remain elusive. Here, a PAM CDPPB, and two NAMs MTEP and MFZ10-7 used as a negative control, were docked to the crystal structure. The docked complexes were submitted to molecular dynamics simulations to examine the activation of the PAM system. An MM/GBSA binding energy calculation was performed to estimate binding strength. Furthermore, molecular switch analysis was done to get insights into conformational changes of the receptor. The PAM CDPPB displays a stronger binding affinity for mGluR5 and induces conformational changes. Also, a salt bridge between TM3 and TM7, corresponding to the ionic lock switch in class A GPCRs is found to be broken. The PAM-induced receptor conformation is more like the agonist-induced conformation than the antagonist-induced conformation, suggesting that PAM works by inducing conformation change and stabilizing the active receptor conformation.


Subject(s)
Benzamides , Molecular Dynamics Simulation , Allosteric Regulation , Benzamides/pharmacology , Pyrazoles/pharmacology
2.
J Chem Inf Model ; 60(8): 4064-4075, 2020 08 24.
Article in English | MEDLINE | ID: mdl-32786510

ABSTRACT

G-protein-coupled receptors (GPCRs) transmit signals into the cell in response to ligand binding at its extracellular domain, which is characterized by the coupling of agonist-induced receptor conformational change to guanine nucleotide (GDP) exchange with guanosine triphosphate on a heterotrimeric (αßγ) guanine nucleotide-binding protein (G-protein), leading to the activation of the G-protein. The signal transduction mechanisms have been widely researched in vivo and in silico. However, coordinated communication from stimulating ligands to the bound GDP still remains elusive. In the present study, we used microsecond (µS) molecular dynamic (MD) simulations to directly probe the communication from the ß2 adrenergic receptor (ß2AR) with an agonist or an antagonist or no ligand to GDP bound to the open conformation of the Gα protein. Molecular mechanism-general Born surface area calculation results indicated either the agonist or the antagonist destabilized the binding between the receptor and the G-protein but the agonist caused a higher level of destabilization than the antagonist. This is consistent with the role of agonist in the activation of the G-protein. Interestingly, while GDP remained bound with the Gα-protein for the two inactive systems (antagonist-bound and apo form), GDP dissociated from the open conformation of the Gα protein for the agonist activated system. Data obtained from MD simulations indicated that the receptor and the Gα subunit play a big role in coordinated communication and nucleotide exchange. Based on residue interaction network analysis, we observed that engagement of agonist-bound ß2AR with an α5 helix of Gα is essential for the GDP release and the residues in the phosphate-binding loop, α1 helix, and α5 helix play very important roles in the GDP release. The insights on GPCR-G-protein communication will facilitate the rational design of agonists and antagonists that target both active and inactive GPCR binding pockets, leading to more precise drugs.


Subject(s)
GTP-Binding Proteins/metabolism , Guanosine Diphosphate/metabolism , Receptors, Adrenergic, beta-2 , Signal Transduction , Humans , Ligands , Protein Binding , Protein Conformation , Receptors, Adrenergic, beta-2/metabolism , Receptors, G-Protein-Coupled/metabolism
3.
Science ; 358(6368): 1235, 2017 Dec 08.
Article in English | MEDLINE | ID: mdl-29217549
6.
Nature ; 524(7563): 127-8, 2015 Aug 06.
Article in English | MEDLINE | ID: mdl-26251860
12.
Nature ; 502(7469): 129-30, 2013 Oct 03.
Article in English | MEDLINE | ID: mdl-24137645
SELECTION OF CITATIONS
SEARCH DETAIL
...